Literature DB >> 19832924

Genetic profiles in renal tumors.

Antonio Lopez-Beltran1, Rodolfo Montironi, Lars Egevad, Maria T Caballero-Vargas, Marina Scarpelli, Ziya Kirkali, Liang Cheng.   

Abstract

Renal cell carcinoma in adult comprises a heterogeneous group of tumors with variable clinical outcomes, which ranges from indolent to aggressively malignant. The application of molecular genetics techniques to the study of renal neoplasms has resulted in improved classification of these entities and better understanding of biological mechanisms responsible for tumor development and progression. In the present article we review the molecular genetic profiles of different renal cell tumors and discuss their relevance to the carcinogenesis mechanisms and to the clinical diagnosis of renal cell carcinoma. Understanding of the molecular genetics of renal tumors is beneficial in making accurate diagnoses, assessing prognoses, and selecting appropriate and targeted therapeutic options.

Entities:  

Mesh:

Year:  2009        PMID: 19832924     DOI: 10.1111/j.1442-2042.2009.02395.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

1.  Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.

Authors:  Kunpeng Liu; Yuan Ren; Lijuan Pang; Yan Qi; Wei Jia; Lin Tao; Zhengyan Hu; Jin Zhao; Haijun Zhang; Li Li; Haifeng Yue; Juan Han; Weihua Liang; Jianming Hu; Hong Zou; Xianglin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.

Authors:  S Karami; E L Yanik; L E Moore; R M Pfeiffer; G Copeland; L Gonsalves; B Y Hernandez; C F Lynch; K Pawlish; E A Engels
Journal:  Am J Transplant       Date:  2016-06-23       Impact factor: 9.369

3.  Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.

Authors:  Samuel Abourbih; Kanishka Sircar; Simon Tanguay; Wassim Kassouf; Armen Aprikian; Jose Mansure; Fadi Brimo
Journal:  World J Surg Oncol       Date:  2013-11-22       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.